Skye Bioscience Inc

SKYENASDAQ · USD
1.73USD+1.45 (+10.30%)
122

Skye Bioscience Inc (SKYE) Option Chain

As of September 18, 2026, Skye Bioscience Inc is trading at $1.73, a +10.30% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 843.0%. IV Rank is 92%.

Read more

Tracking the SKYE option chain helps you see every strike and expiry on Skye Bioscience Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Skye Bioscience Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of SKYE options activity at a glance. Use our scanner to monitor the SKYE option chain in real time and filter for the SKYE options trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For SKYE stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the SKYE option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where SKYE stock options are being actively traded and where they are not.

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. Skye Bioscience, Inc.

was founded in 2012 and is headquartered in San Diego, California.

Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Skye Bioscience Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen SKYE options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of SKYE stock options — let the full option chain come to you, pre-filtered and ready to trade.

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV percentile92.46% Elevated
  • Market cap (M$)10
  • 52 weeks high-94.39%
  • 52 weeks low0.00%
  • Analyst recommendationBuy
    2.00
  • Target price$7.00
    304.25% above the current stock price
  • Dividend
  • Payout ratio
  • Earnings date2026-11-09
  • P/E
  • Future P/E
  • EPS (ttm)-1.27
  • EPS growth next 5 years0.07%

As of September 18, 2026

2026-10-16
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
98.95000.500.000.502.50+792.861.702.750.771.46001.05
99.41000.500.000.505.00+1685.714.205.303.271.48000.59
99.59000.500.000.507.50+2578.576.707.805.771.48000.41

As of September 18, 2026

Scan the full option chain in one place

Browse the full SKYE option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.

Start your 14-day free trial